MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

Stage 4 neuroblastoma (NB) are heterogeneous regarding their clinical presentations and behavior. Indeed infants (stage 4S and non-stage 4S of age 365 days). Our study aimed at: (i) identifying age-based genomic and gene expression profiles of stage 4 NB supporting this clinical stratification; and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular oncology 2008-10, Vol.2 (3), p.261-271
Hauptverfasser: Bénard, Jean, Raguénez, Gilda, Kauffmann, Audrey, Valent, Alexander, Ripoche, Hugues, Joulin, Virginie, Job, Bastien, Danglot, Gisèle, Cantais, Sabrina, Robert, Thomas, Terrier-Lacombe, Marie-José, Chassevent, Agnès, Koscielny, Serge, Fischer, Matthias, Berthold, Frank, Lipinski, Marc, Tursz, Thomas, Dessen, Philippe, Lazar, Vladimir, Valteau-Couanet, Dominique
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 271
container_issue 3
container_start_page 261
container_title Molecular oncology
container_volume 2
creator Bénard, Jean
Raguénez, Gilda
Kauffmann, Audrey
Valent, Alexander
Ripoche, Hugues
Joulin, Virginie
Job, Bastien
Danglot, Gisèle
Cantais, Sabrina
Robert, Thomas
Terrier-Lacombe, Marie-José
Chassevent, Agnès
Koscielny, Serge
Fischer, Matthias
Berthold, Frank
Lipinski, Marc
Tursz, Thomas
Dessen, Philippe
Lazar, Vladimir
Valteau-Couanet, Dominique
description Stage 4 neuroblastoma (NB) are heterogeneous regarding their clinical presentations and behavior. Indeed infants (stage 4S and non-stage 4S of age 365 days). Our study aimed at: (i) identifying age-based genomic and gene expression profiles of stage 4 NB supporting this clinical stratification; and (ii) finding a stage 4S NB signature. Differential genome and transcriptome analyses of a learning set of MYCN-non amplified stage 4 NB tumors at diagnosis ( n = 29 tumors including 12 stage 4S) were performed using 1Mb BAC microarrays and Agilent 22K probes oligo-microarrays. mRNA chips data following filtering yielded informative genes before supervised hierarchical clustering to identify relationship among tumor samples. After confirmation by quantitative RT-PCR, a stage 4S NB's gene cluster was obtained and submitted to a validation set ( n = 22 tumors). Genomic abnormalities of infant's tumors (whole chromosomes gains or loss) differ radically from that of children (intra-chromosomal rearrangements) but could not discriminate infants with 4S from those without this presentation. In contrast, differential gene expression by looking at both individual genes and whole biological pathways leads to a molecular stage 4S NB portrait which provides new biological clues about this fascinating entity.
doi_str_mv 10.1016/j.molonc.2008.07.002
format Article
fullrecord <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5527812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1574789108000926</els_id><sourcerecordid>2299178818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5761-21f51b14609c0aeff1b690eb9dac51c51cdcb51874c7f774615c45134e4c92ce3</originalsourceid><addsrcrecordid>eNqNUl2L1DAULaK46-o_EAkIvnXMTZOm8UFZBr9g131QH3wKaXo7m6FNukm7y4I_3gwzuOqDCoHkknMP59x7iuIp0BVQqF9uV2MYgrcrRmmzonJFKbtXHEMjm5KyGu7nt5C8lI2Co-JRSltKRa1q9bA4AlU1VcXlcfH9_Nv6U-mDL804Da532JERZ5NmMztLPC4xtEMuw2jIjZsvySaEjkwxbHxILhHjO5Km4GfjMSyJRNxETMkF_4qckiwR7TKYSKYQ52jcTEJPMvkGCf_8uHjQmyHhk8N9Unx99_bL-kN5dvH-4_r0rLRC1lAy6AW0wGuqLDXY99DWimKrOmMF7E5nW5GNcyt7KXkNwnIBFUduFbNYnRSv97zT0o7YWfRZyqCn6EYTb3UwTv_-492l3oRrLQSTDbBM8OJAEMPVgmnWo0sWh2FvWte1BODVv4GgBBWNaDLw-R_AbViiz1PQjCkFsmlgh-J7lI0hpYj9T81A9S4Feqv3KdC7FGgqdU5Bbnv2q9-7psPaM-DNHnDjBrz9L1J9fnHGdjWrcrjuRop5b9cOo07WobfYuYh21l1wf9f4A8PJ22w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2299178818</pqid></control><display><type>article</type><title>MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S</title><source>Wiley Online Library Open Access</source><creator>Bénard, Jean ; Raguénez, Gilda ; Kauffmann, Audrey ; Valent, Alexander ; Ripoche, Hugues ; Joulin, Virginie ; Job, Bastien ; Danglot, Gisèle ; Cantais, Sabrina ; Robert, Thomas ; Terrier-Lacombe, Marie-José ; Chassevent, Agnès ; Koscielny, Serge ; Fischer, Matthias ; Berthold, Frank ; Lipinski, Marc ; Tursz, Thomas ; Dessen, Philippe ; Lazar, Vladimir ; Valteau-Couanet, Dominique</creator><creatorcontrib>Bénard, Jean ; Raguénez, Gilda ; Kauffmann, Audrey ; Valent, Alexander ; Ripoche, Hugues ; Joulin, Virginie ; Job, Bastien ; Danglot, Gisèle ; Cantais, Sabrina ; Robert, Thomas ; Terrier-Lacombe, Marie-José ; Chassevent, Agnès ; Koscielny, Serge ; Fischer, Matthias ; Berthold, Frank ; Lipinski, Marc ; Tursz, Thomas ; Dessen, Philippe ; Lazar, Vladimir ; Valteau-Couanet, Dominique</creatorcontrib><description>Stage 4 neuroblastoma (NB) are heterogeneous regarding their clinical presentations and behavior. Indeed infants (stage 4S and non-stage 4S of age &lt;365 days at diagnosis) show regression contrasting with progression in children (&gt;365 days). Our study aimed at: (i) identifying age-based genomic and gene expression profiles of stage 4 NB supporting this clinical stratification; and (ii) finding a stage 4S NB signature. Differential genome and transcriptome analyses of a learning set of MYCN-non amplified stage 4 NB tumors at diagnosis ( n = 29 tumors including 12 stage 4S) were performed using 1Mb BAC microarrays and Agilent 22K probes oligo-microarrays. mRNA chips data following filtering yielded informative genes before supervised hierarchical clustering to identify relationship among tumor samples. After confirmation by quantitative RT-PCR, a stage 4S NB's gene cluster was obtained and submitted to a validation set ( n = 22 tumors). Genomic abnormalities of infant's tumors (whole chromosomes gains or loss) differ radically from that of children (intra-chromosomal rearrangements) but could not discriminate infants with 4S from those without this presentation. In contrast, differential gene expression by looking at both individual genes and whole biological pathways leads to a molecular stage 4S NB portrait which provides new biological clues about this fascinating entity.</description><identifier>ISSN: 1574-7891</identifier><identifier>EISSN: 1878-0261</identifier><identifier>DOI: 10.1016/j.molonc.2008.07.002</identifier><identifier>PMID: 19383347</identifier><language>eng</language><publisher>United States: Elsevier B.V</publisher><subject>Age ; Age Factors ; Artificial Intelligence ; Bone marrow ; Child, Preschool ; Children ; Chromosome rearrangements ; Deoxyribonucleic acid ; Diagnosis ; Disease ; DNA ; DNA microarrays ; DNA probes ; Experiments ; Female ; Gene expression ; Gene Expression Profiling - methods ; Genomes ; Genomics ; Humans ; Infant ; Infants ; Learning set ; Male ; Metastases ; Metastasis ; Metastatic neuroblastoma ; Molecular Diagnostic Techniques ; Molecular signature ; N-Myc Proto-Oncogene Protein ; Neoplasm Metastasis - genetics ; Neoplasm Metastasis - pathology ; Neuroblastoma ; Neuroblastoma - genetics ; Neuroblastoma - pathology ; Nuclear Proteins ; Oncogene Proteins ; Patients ; Prognosis ; Remission, Spontaneous ; Software ; Stage 4S ; Tumors</subject><ispartof>Molecular oncology, 2008-10, Vol.2 (3), p.261-271</ispartof><rights>2008 Federation of European Biochemical Societies</rights><rights>2008. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5761-21f51b14609c0aeff1b690eb9dac51c51cdcb51874c7f774615c45134e4c92ce3</citedby><cites>FETCH-LOGICAL-c5761-21f51b14609c0aeff1b690eb9dac51c51cdcb51874c7f774615c45134e4c92ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527812/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1574789108000926$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,3537,11541,27901,27902,45550,45551,46027,46451,53766,53768,65534</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.molonc.2008.07.002$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19383347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bénard, Jean</creatorcontrib><creatorcontrib>Raguénez, Gilda</creatorcontrib><creatorcontrib>Kauffmann, Audrey</creatorcontrib><creatorcontrib>Valent, Alexander</creatorcontrib><creatorcontrib>Ripoche, Hugues</creatorcontrib><creatorcontrib>Joulin, Virginie</creatorcontrib><creatorcontrib>Job, Bastien</creatorcontrib><creatorcontrib>Danglot, Gisèle</creatorcontrib><creatorcontrib>Cantais, Sabrina</creatorcontrib><creatorcontrib>Robert, Thomas</creatorcontrib><creatorcontrib>Terrier-Lacombe, Marie-José</creatorcontrib><creatorcontrib>Chassevent, Agnès</creatorcontrib><creatorcontrib>Koscielny, Serge</creatorcontrib><creatorcontrib>Fischer, Matthias</creatorcontrib><creatorcontrib>Berthold, Frank</creatorcontrib><creatorcontrib>Lipinski, Marc</creatorcontrib><creatorcontrib>Tursz, Thomas</creatorcontrib><creatorcontrib>Dessen, Philippe</creatorcontrib><creatorcontrib>Lazar, Vladimir</creatorcontrib><creatorcontrib>Valteau-Couanet, Dominique</creatorcontrib><title>MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S</title><title>Molecular oncology</title><addtitle>Mol Oncol</addtitle><description>Stage 4 neuroblastoma (NB) are heterogeneous regarding their clinical presentations and behavior. Indeed infants (stage 4S and non-stage 4S of age &lt;365 days at diagnosis) show regression contrasting with progression in children (&gt;365 days). Our study aimed at: (i) identifying age-based genomic and gene expression profiles of stage 4 NB supporting this clinical stratification; and (ii) finding a stage 4S NB signature. Differential genome and transcriptome analyses of a learning set of MYCN-non amplified stage 4 NB tumors at diagnosis ( n = 29 tumors including 12 stage 4S) were performed using 1Mb BAC microarrays and Agilent 22K probes oligo-microarrays. mRNA chips data following filtering yielded informative genes before supervised hierarchical clustering to identify relationship among tumor samples. After confirmation by quantitative RT-PCR, a stage 4S NB's gene cluster was obtained and submitted to a validation set ( n = 22 tumors). Genomic abnormalities of infant's tumors (whole chromosomes gains or loss) differ radically from that of children (intra-chromosomal rearrangements) but could not discriminate infants with 4S from those without this presentation. In contrast, differential gene expression by looking at both individual genes and whole biological pathways leads to a molecular stage 4S NB portrait which provides new biological clues about this fascinating entity.</description><subject>Age</subject><subject>Age Factors</subject><subject>Artificial Intelligence</subject><subject>Bone marrow</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Chromosome rearrangements</subject><subject>Deoxyribonucleic acid</subject><subject>Diagnosis</subject><subject>Disease</subject><subject>DNA</subject><subject>DNA microarrays</subject><subject>DNA probes</subject><subject>Experiments</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Profiling - methods</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Humans</subject><subject>Infant</subject><subject>Infants</subject><subject>Learning set</subject><subject>Male</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Metastatic neuroblastoma</subject><subject>Molecular Diagnostic Techniques</subject><subject>Molecular signature</subject><subject>N-Myc Proto-Oncogene Protein</subject><subject>Neoplasm Metastasis - genetics</subject><subject>Neoplasm Metastasis - pathology</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - genetics</subject><subject>Neuroblastoma - pathology</subject><subject>Nuclear Proteins</subject><subject>Oncogene Proteins</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Remission, Spontaneous</subject><subject>Software</subject><subject>Stage 4S</subject><subject>Tumors</subject><issn>1574-7891</issn><issn>1878-0261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNUl2L1DAULaK46-o_EAkIvnXMTZOm8UFZBr9g131QH3wKaXo7m6FNukm7y4I_3gwzuOqDCoHkknMP59x7iuIp0BVQqF9uV2MYgrcrRmmzonJFKbtXHEMjm5KyGu7nt5C8lI2Co-JRSltKRa1q9bA4AlU1VcXlcfH9_Nv6U-mDL804Da532JERZ5NmMztLPC4xtEMuw2jIjZsvySaEjkwxbHxILhHjO5Km4GfjMSyJRNxETMkF_4qckiwR7TKYSKYQ52jcTEJPMvkGCf_8uHjQmyHhk8N9Unx99_bL-kN5dvH-4_r0rLRC1lAy6AW0wGuqLDXY99DWimKrOmMF7E5nW5GNcyt7KXkNwnIBFUduFbNYnRSv97zT0o7YWfRZyqCn6EYTb3UwTv_-492l3oRrLQSTDbBM8OJAEMPVgmnWo0sWh2FvWte1BODVv4GgBBWNaDLw-R_AbViiz1PQjCkFsmlgh-J7lI0hpYj9T81A9S4Feqv3KdC7FGgqdU5Bbnv2q9-7psPaM-DNHnDjBrz9L1J9fnHGdjWrcrjuRop5b9cOo07WobfYuYh21l1wf9f4A8PJ22w</recordid><startdate>200810</startdate><enddate>200810</enddate><creator>Bénard, Jean</creator><creator>Raguénez, Gilda</creator><creator>Kauffmann, Audrey</creator><creator>Valent, Alexander</creator><creator>Ripoche, Hugues</creator><creator>Joulin, Virginie</creator><creator>Job, Bastien</creator><creator>Danglot, Gisèle</creator><creator>Cantais, Sabrina</creator><creator>Robert, Thomas</creator><creator>Terrier-Lacombe, Marie-José</creator><creator>Chassevent, Agnès</creator><creator>Koscielny, Serge</creator><creator>Fischer, Matthias</creator><creator>Berthold, Frank</creator><creator>Lipinski, Marc</creator><creator>Tursz, Thomas</creator><creator>Dessen, Philippe</creator><creator>Lazar, Vladimir</creator><creator>Valteau-Couanet, Dominique</creator><general>Elsevier B.V</general><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200810</creationdate><title>MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S</title><author>Bénard, Jean ; Raguénez, Gilda ; Kauffmann, Audrey ; Valent, Alexander ; Ripoche, Hugues ; Joulin, Virginie ; Job, Bastien ; Danglot, Gisèle ; Cantais, Sabrina ; Robert, Thomas ; Terrier-Lacombe, Marie-José ; Chassevent, Agnès ; Koscielny, Serge ; Fischer, Matthias ; Berthold, Frank ; Lipinski, Marc ; Tursz, Thomas ; Dessen, Philippe ; Lazar, Vladimir ; Valteau-Couanet, Dominique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5761-21f51b14609c0aeff1b690eb9dac51c51cdcb51874c7f774615c45134e4c92ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Age</topic><topic>Age Factors</topic><topic>Artificial Intelligence</topic><topic>Bone marrow</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Chromosome rearrangements</topic><topic>Deoxyribonucleic acid</topic><topic>Diagnosis</topic><topic>Disease</topic><topic>DNA</topic><topic>DNA microarrays</topic><topic>DNA probes</topic><topic>Experiments</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Profiling - methods</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Humans</topic><topic>Infant</topic><topic>Infants</topic><topic>Learning set</topic><topic>Male</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Metastatic neuroblastoma</topic><topic>Molecular Diagnostic Techniques</topic><topic>Molecular signature</topic><topic>N-Myc Proto-Oncogene Protein</topic><topic>Neoplasm Metastasis - genetics</topic><topic>Neoplasm Metastasis - pathology</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - genetics</topic><topic>Neuroblastoma - pathology</topic><topic>Nuclear Proteins</topic><topic>Oncogene Proteins</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Remission, Spontaneous</topic><topic>Software</topic><topic>Stage 4S</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bénard, Jean</creatorcontrib><creatorcontrib>Raguénez, Gilda</creatorcontrib><creatorcontrib>Kauffmann, Audrey</creatorcontrib><creatorcontrib>Valent, Alexander</creatorcontrib><creatorcontrib>Ripoche, Hugues</creatorcontrib><creatorcontrib>Joulin, Virginie</creatorcontrib><creatorcontrib>Job, Bastien</creatorcontrib><creatorcontrib>Danglot, Gisèle</creatorcontrib><creatorcontrib>Cantais, Sabrina</creatorcontrib><creatorcontrib>Robert, Thomas</creatorcontrib><creatorcontrib>Terrier-Lacombe, Marie-José</creatorcontrib><creatorcontrib>Chassevent, Agnès</creatorcontrib><creatorcontrib>Koscielny, Serge</creatorcontrib><creatorcontrib>Fischer, Matthias</creatorcontrib><creatorcontrib>Berthold, Frank</creatorcontrib><creatorcontrib>Lipinski, Marc</creatorcontrib><creatorcontrib>Tursz, Thomas</creatorcontrib><creatorcontrib>Dessen, Philippe</creatorcontrib><creatorcontrib>Lazar, Vladimir</creatorcontrib><creatorcontrib>Valteau-Couanet, Dominique</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bénard, Jean</au><au>Raguénez, Gilda</au><au>Kauffmann, Audrey</au><au>Valent, Alexander</au><au>Ripoche, Hugues</au><au>Joulin, Virginie</au><au>Job, Bastien</au><au>Danglot, Gisèle</au><au>Cantais, Sabrina</au><au>Robert, Thomas</au><au>Terrier-Lacombe, Marie-José</au><au>Chassevent, Agnès</au><au>Koscielny, Serge</au><au>Fischer, Matthias</au><au>Berthold, Frank</au><au>Lipinski, Marc</au><au>Tursz, Thomas</au><au>Dessen, Philippe</au><au>Lazar, Vladimir</au><au>Valteau-Couanet, Dominique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S</atitle><jtitle>Molecular oncology</jtitle><addtitle>Mol Oncol</addtitle><date>2008-10</date><risdate>2008</risdate><volume>2</volume><issue>3</issue><spage>261</spage><epage>271</epage><pages>261-271</pages><issn>1574-7891</issn><eissn>1878-0261</eissn><abstract>Stage 4 neuroblastoma (NB) are heterogeneous regarding their clinical presentations and behavior. Indeed infants (stage 4S and non-stage 4S of age &lt;365 days at diagnosis) show regression contrasting with progression in children (&gt;365 days). Our study aimed at: (i) identifying age-based genomic and gene expression profiles of stage 4 NB supporting this clinical stratification; and (ii) finding a stage 4S NB signature. Differential genome and transcriptome analyses of a learning set of MYCN-non amplified stage 4 NB tumors at diagnosis ( n = 29 tumors including 12 stage 4S) were performed using 1Mb BAC microarrays and Agilent 22K probes oligo-microarrays. mRNA chips data following filtering yielded informative genes before supervised hierarchical clustering to identify relationship among tumor samples. After confirmation by quantitative RT-PCR, a stage 4S NB's gene cluster was obtained and submitted to a validation set ( n = 22 tumors). Genomic abnormalities of infant's tumors (whole chromosomes gains or loss) differ radically from that of children (intra-chromosomal rearrangements) but could not discriminate infants with 4S from those without this presentation. In contrast, differential gene expression by looking at both individual genes and whole biological pathways leads to a molecular stage 4S NB portrait which provides new biological clues about this fascinating entity.</abstract><cop>United States</cop><pub>Elsevier B.V</pub><pmid>19383347</pmid><doi>10.1016/j.molonc.2008.07.002</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1574-7891
ispartof Molecular oncology, 2008-10, Vol.2 (3), p.261-271
issn 1574-7891
1878-0261
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5527812
source Wiley Online Library Open Access
subjects Age
Age Factors
Artificial Intelligence
Bone marrow
Child, Preschool
Children
Chromosome rearrangements
Deoxyribonucleic acid
Diagnosis
Disease
DNA
DNA microarrays
DNA probes
Experiments
Female
Gene expression
Gene Expression Profiling - methods
Genomes
Genomics
Humans
Infant
Infants
Learning set
Male
Metastases
Metastasis
Metastatic neuroblastoma
Molecular Diagnostic Techniques
Molecular signature
N-Myc Proto-Oncogene Protein
Neoplasm Metastasis - genetics
Neoplasm Metastasis - pathology
Neuroblastoma
Neuroblastoma - genetics
Neuroblastoma - pathology
Nuclear Proteins
Oncogene Proteins
Patients
Prognosis
Remission, Spontaneous
Software
Stage 4S
Tumors
title MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A26%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MYCN-non-amplified%20metastatic%20neuroblastoma%20with%20good%20prognosis%20and%20spontaneous%20regression:%20A%20molecular%20portrait%20of%20stage%204S&rft.jtitle=Molecular%20oncology&rft.au=B%C3%A9nard,%20Jean&rft.date=2008-10&rft.volume=2&rft.issue=3&rft.spage=261&rft.epage=271&rft.pages=261-271&rft.issn=1574-7891&rft.eissn=1878-0261&rft_id=info:doi/10.1016/j.molonc.2008.07.002&rft_dat=%3Cproquest_24P%3E2299178818%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2299178818&rft_id=info:pmid/19383347&rft_els_id=S1574789108000926&rfr_iscdi=true